As the suppressive immune regulatory molecule PD-L1 was upregulated on CT26 cells in vitro after stimulation with CV8102 (Fig. 1b), we speculated this could suppress tumor-infiltrating lymphocytes and thereby partially counteract the immune stimulatory effects of the CV8102-induced cytokines. The gene discussed is CD274; the disease is neoplasm.